Blog Listing

March 24 Newsletter

EVIDENCE BASED TRADING – Dr. James C Krider

March 24, 2017, momentum stock universe.

3-24-17 Dr Krider 30-day 3-24-17 Dr Krider YTD

Dr. Krider’s managed portfolio YTD performance is 7.86% compared to the S&P 500’s 5.20%. This includes option trades. Dr. Krider’s 30-day trailing performance, including option trades, relative to the S&P 500 is 2.60% to -0.84%.

Dr. James Krider creates a new stock portfolio monthly consisting of quality momentum stocks. Most portfolios contain 20 stocks and are active for three months. The portfolio is managed per the guidelines provided in the educational section   To view the currently active portfolios, go to Dr. Krider’s momentum stock universe. It is completely free and updated weekly.

To follow the actual and pending trades, subscribe to our premium service.

Dr. Krider’s managed portfolio includes option trades.

Disclosure: I am long in AAPL, ABX, ACAD, AMAT, ANTM, ARCC, AVGO, BAC, BX, CI, CIEN, DD, DIS, DOW, FB, GLW, LRCX, MBT, MO, OLN, ORN, S, SPY, STX, TMUS, TXN, V, WDC, and X.  I hold option positions in CIEN, MOMO, MU, NVDA, OLN, RHT, STX, TMUS, UAL, VIPS, and WB.

MARKET REVIEW        

Three-month chart: Minor support has been broken and the SPY is now trading below the regression channel for the last three trading days. MA60 slope continues to decline.

3-24-17 3 month

One-month chart: The SPY is trading below the MA20 and at the bottom of the of the regression channel The MA20 is negative as is the ROC.

3-24-17 one month

Technical analysis is bearish for the short-term (30-days), neutral for the intermediate-term, and bullish for the long-term timeframes.

Overall: We have entered a period of market stagnation with a sideways movement. The old minor support at $236.35 is now resistance. On the short-term we are definitely bearish and need to play the market as such. We are still bullish on the long-term.

NEXT WEEKS PLAN

I am now down to 47% invested in stock. This represents momentum stocks and stocks assigned to me from option trades. Currently I have 8 stocks outside of the momentum group. I have 11 puts short going into next week. I will not be selling any more puts until the market shows evidence of an upturn. In the meanwhile, I will sell covered calls on the eight option stocks I currently own and will maintain the trailing stops on the momentum stocks.

The premium service has all my option and momentum trades that you can follow in real time.

To view the complete list of current momentum stocks, go to the momentum universe page. This is a free service.

Happy trading,

Dr. James Krider MD

 

 

 

 

 

James Krider, MD

Dr. James C Krider is a practicing family physician in Apple Valley, CA. Dr. Krider is a licensed insurance agent in the states of California (0I65488) and Nevada specializing in Medicare Advantage and Life insurance, an important aspect of wealth planning.

Dr. James C Krider is an Investment Advisor Representative licensed in the state of Nevada and is President of Krider Wealth Management, an Investment Advisory corporation in Nevada.

These comments were prepared by James Krider, MD, an investment advisor representative of Krider Wealth Management, LLC, a Nevada state registered investment advisor. The information herein was obtained from various sources believed to be reliable; however, we do not guarantee its accuracy or completeness. The information in this report is given as of the date indicated. We assume no obligation to update this information, or advise on further developments relating to securities discussed in this report. Opinions expressed are subject to change without notice. Opinions of individual representatives may not be those of the Firm. Additional information is available upon request. The information contained in this document is prepared for general circulation and is circulated for general information only. It does not address specific investment objectives, or the financial situation and the particular needs of any recipient. Investors should not attempt to make investment decisions solely based on the information contained in this communication as it does not offer enough information to make such decisions and may not be suitable for your personal financial circumstances. You should consult with your financial professional prior to making such decisions. PAST PERFORMANCE SHOULD NOT BE CONSIDERED INDICATIVE OF FUTURE PERFORMANCE. ANY INVESTMENT CONTAINS RISK INCLUDING THE RISK OF TOTAL LOSS. This document does not constitute an offer, or an invitation to make an offer, to buy or sell any securities discussed herein.


Leave a Reply